The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification

E-ISSN： 1873-4286|14|36|3780-3789

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.36, 2008-12, pp. : 3780-3789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor endothelial markers as a target in cancer

By Ribatti Domenico Ranieri Girolamo Basile Antonio Azzariti Amalia Paradiso Angelo Vacca Angelo

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1215-1225

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 865-874

Bentham Science Publishers

Access to resources Recommend Favorite

14-3-3ζ as a prognostic marker and therapeutic target for cancer

By Neal Christopher L Yu Dihua

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1343-1354

Informa Healthcare

Access to resources Recommend Favorite

Circulating Tumor Cells in Cancer Therapy: Are we off Target?

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 509-518

Bentham Science Publishers

Access to resources Recommend Favorite

Survivin as a Prognostic/Predictive Marker and Molecular Target in Cancer Therapy

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. : 3679-3688

Bentham Science Publishers

Access to resources Recommend Favorite